相关实验视频
Updated: May 5, 2026

11:53
Cecal Ligation Puncture Procedure
Published on: May 7, 2011
55.2K
在患有慢性病的患者中使用他类药物和败血症事件[修正]
Rajesh Gupta1, Laura C Plantinga, Nancy E Fink
1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Md, USA.
JAMA
|April 5, 2007
概括
静止剂的使用显著降低了慢性脏病透析患者的败血症风险. 建议进行进一步的研究来确认他类药物.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心血管医学 心血管医学
- 传染病流行病学 传染病流行病学
背景情况:
- 经过透析的慢性病 (CKD) 患者面临着败血症和相关死亡风险的增加.
- 败血症在CKD患者群体中代表着重大的临床挑战.
研究的目的:
- 调查使用他类药物和在接受透析的患者中发生败血症事件的发生率之间的关联.
- 为了确定他类药物是否在这个高危人群中提供抗败血症的保护作用.
主要方法:
- 一项全国前性队列研究,涉及81家美国诊所的1041名事件透析患者.
- 通过医疗记录确定了他类药物的使用;通过美国脏数据系统追踪毒症事件,平均随访时间为3.4年.
- 使用多变量回归和倾向分数匹配来比较他类药物使用者和非使用者之间的败血症率,控制混因素.
主要成果:
- 在他类药物使用者中,败血症发病率明显较低 (41/1000患者年),而非使用者 (110/1000患者年).
- 经过调整后的分析显示,他类药物的使用独立地与降低了败血症住院的风险有关 (发病率比率:0.38;95% CI,0.21-0.67).
- 倾向性得分匹配进一步加强了观察到的保护作用,显示了对他类药物使用者的败血症风险的更大降低 (发生率比:0.24;95% CI,0.11-0.49).
结论:
- 达丁类药物的使用显示出强烈的,独立的关联,降低了透析中CKD患者的败血症风险.
- 这些发现表明,他类药物可能在这个脆弱人群中起到预防败血症的作用.
- 随机对照试验是必要的,以评估他类药物在预防CKD患者中败血症的疗效.
更多相关视频
相关概念视频
Acute Kidney Injury I: Introduction
1.5K
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.5K
Acute Kidney Injury II: Pathophysiology
2.4K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.4K
Acute Kidney Injury III: Clinical Manifestations
1.8K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.8K
Acute Kidney Injury IV: Diagnostic Studies and Prevention
582
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
582
Acute Kidney Injury V: Interprofessional Care
548
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
548
Chronic Kidney Disease III: Interprofessional Care
706
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
706

